-
OLA1 is a stress-responsive NTPase hub at the interface of translation
initiation control, proteostasis, and mitonuclear communication.
"Obg-like ATPase 1 (OLA1; also called GTPBP9/DOC45) is the human eukaryotic homolog of the universally conserved YchF/Ola1 family of TRAFAC/Obg-like P-loop NTPases. It is an atypical NTPase that can bind/hydrolyze ATP and GTP but shows structural features favoring ATP, and it integrates stress signaling with translation initiation control, proteostasis, and mitochondria-nucleus (retrograde) communication.
"
-
ERK-driven phosphorylation switches OLA1 localization (cytoplasm/mitochondria
to nucleus) and enzymatic activity (ATPase to GTPase), enabling
stress-coupled regulation of nuclear-encoded mitochondrial bioenergetic
programs.
"Recent 2023 work provides a mechanistic framework in which ERK1/2-dependent phosphorylation controls OLA1's subcellular localization and switches its biochemical activity, thereby enabling OLA1 to act as a stress-responsive regulator of nuclear-encoded mitochondrial bioenergetic programs.
"
-
Domain architecture is conserved across the YchF/OLA1 family with an
N-terminal G/NTPase domain, helical/coiled-coil domain, and C-terminal
TGS domain (RNA-binding).
"The YchF/Ola1 proteins are described as conserved three-domain proteins comprising an N-terminal G (NTPase) domain, a helical/coiled-coil domain, and a C-terminal TGS domain (often associated with RNA-binding functions).
"
-
The atypical G4 motif (NxxE instead of canonical NKxD) underlies altered
nucleotide specificity and bias toward ATP.
"A defining feature is a non-canonical G4 motif (often NxxE rather than the canonical NKxD), which is proposed to underlie altered nucleotide specificity and ATP preference relative to typical GTPases.
"
-
OLA1 has a strong mitochondrial pool localizing to the outer mitochondrial
membrane in pulmonary vascular cells.
"In pulmonary vascular cells, OLA1 shows a strong mitochondrial pool and is reported to localize to the outer mitochondrial membrane (supported by biochemical fractionation/protease protection and marker co-staining).
"
-
Stress-induced nuclear translocation of OLA1 depends on ERK phosphorylation,
importin-alpha1 (KPNA2), and vimentin.
"Cellular stresses (hypoxia, H2O2, mitochondrial uncoupling) induce nuclear accumulation of OLA1, with mechanistic dependence on ERK phosphorylation and nuclear import machinery (importin-alpha1) and the cytoskeletal intermediate filament vimentin.
"
-
Phospho-T325 OLA1 has increased GTPase activity, reduced ATPase activity,
and potentiated DNA binding.
"ERK2 phosphorylation at Thr325 alters OLA1 biochemical behavior and DNA binding, with evidence that T325 phosphorylation increases GTPase activity and suppresses ATPase activity and potentiates DNA binding.
"
-
OLA1 binds eIF2 and inhibits ternary-complex formation, modulating the
integrated stress response.
"OLA1 is reported to bind eIF2 and to inhibit translation initiation by preventing formation of the eIF2.GTP.Met-tRNAi ternary complex, thereby modulating pathways central to the integrated stress response (ISR).
"
-
OLA1 supports proteostasis via HSP70 stabilization and influences the
CHIP/HSP70/SOD2 axis for oxidative stress control.
"OLA1 has been linked to heat-shock resilience via HSP70 stabilization and to oxidative stress control through effects on the CHIP/HSP70/SOD2 axis.
"
-
OLA1 depletion downregulates nuclear genes for oxidative phosphorylation
and mitochondrial assembly; T325D rescues but T325A does not.
"OLA1 depletion downregulates nuclear genes involved in oxidative phosphorylation and mitochondrial assembly/structure; phosphomimetic nuclear OLA1 (T325D) rescues mitochondrial gene expression better than phosphoresistant T325A.
"
-
OLA1 deficiency in endothelial cells lowers ATP, raises lactate, and
increases the ADP:ATP ratio.
"Functional metabolic outcomes include lower cellular ATP, higher lactate, and increased ADP:ATP ratio in OLA1-deficient endothelial cells.
"
-
OLA1 is a translational regulator of p21 with links to P21/CDK2-related
tumor progression in clinical/translational studies.
"OLA1 is described as a translational regulator of p21, and clinical/translational studies link OLA1 to P21/CDK2-related tumor progression models.
"
-
OLA1 is implicated in BRCA1/BARD1-dependent centrosome regulation, bridging
stress response and genome stability.
"OLA1 is described as DNA-damage regulated (DOC45) and a BRCA1/BARD1-interacting factor implicated in centrosome regulation, providing a mechanistic bridge between stress responses and genome stability phenotypes.
"